Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Prime Medicine (PRME) Return on Sales: 2025

Historic Return on Sales for Prime Medicine (PRME) over the last 1 years, with Sep 2025 value amounting to -33.39%.

  • Prime Medicine's Return on Sales was N/A to -33.39% in Q3 2025 from the same period last year, while for Sep 2025 it was -33.39%, marking a year-over-year change of. This contributed to the annual value of -65.67% for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Prime Medicine's Return on Sales is -33.39%, which was up 16.87% from -40.17% recorded in Q2 2025.
  • Over the past 5 years, Prime Medicine's Return on Sales peaked at -33.39% during Q3 2025, and registered a low of -45.53% during Q1 2025.
  • In the last 1 years, Prime Medicine's Return on Sales had a median value of -40.17% in 2025 and averaged -39.70%.